Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

Cellmid secures partnership with Bloomingdales to sell évolis®

évolis® Professional is an anti-ageing hair care product range.

Cellmid Ltd (ASX:CDY) has secured a new premium retail partnership with leading US retailer, Bloomingdales, for its évolis® Professional product range.

The in-store launch is planned for the upcoming September quarter at Bloomingdales, one of the oldest and most prestigious department stores in the US.

Bloomingdales is known for luxury skincare and is an ideal partner for évolis® Professional.

WATCH: Cellmid gaining ground in USA and China following advances in Japan and Australia

Cellmid’s CEO Maria Halasz said: “Bloomingdales represents the third premium retail group in the USA for évolis® Professional.

"With our successful online business in Neiman Marcus, recent commencement of online sales via US based Soft Surroundings and now securing a partnership with Bloomingdales, our USA distribution strategy is clearly working.

“Overall, we are confident that our business focus to develop and market only clinically validated “first in class, best in class” consumer products will deliver growth for our shareholders.”

READ: Cellmid's year-to-date sales exceed full-year sales for 2017 with further momentum expected

Bloomingdales is one of the oldest and most prestigious department stores in the US established in 1872 and currently owned by Macy’s, Inc (NYSE:M).

Bloomingdales will stock évolis® Professional in its retail stores and online channels.

Sales are expected to commence in the upcoming September quarter.

READ: Cellmid strengthens its position in hair and skin care market with leading anti-ageing product

Cellmid’s consumer health subsidiary Advangen generates all of the company’s revenue.

The consumer health segment sells hair growth products such as évolis® in Australia, Japan and the US, which were developed using FGF5 related intellectual property.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK